Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02863601 · ClinicalTrials.gov registry record
Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 25
- Enrollment target
NCT02863601: Completed study, sponsored by University of Pittsburgh.
NCT02863601 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02863601 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine whether buprenorphine and metabolite exposure (reflected as the dose-adjusted plasma concentration x time curve \[AUC\]) differs during pregnancy and between pregnancy and the postpartum state.The study will define the pharmacokinetics of buprenorphine and determine if there is a better way to gauge dosing based on objective, physiological parameters of satiety. The study will define neonatal exposure to buprenorphine through breast milk.
Primary Outcome
We will define the pharmacokinetics of BUP in early and late pregnancy and the postpartum period and determine what contributes to the variation in plasma concentrations and response.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-08 |
| Est. Completion | 2022-05 |
What the finished NCT02863601 record still lists
NCT02863601 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02863601 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02863601 about?
NCT02863601 is a clinical study titled "Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics". The primary purpose of this study is to determine whether buprenorphine and metabolite exposure (reflected as the dose-adjusted plasma concentration x time curve \[AUC\]) differs during pregnancy and between pregnancy and the postpartum state.The study will define the pharmacokinetics of buprenorphi...
What is the current status of trial NCT02863601?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2016-08. Estimated completion is 2022-05.
Who is sponsoring clinical trial NCT02863601?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia